The Racing Medication and Testing Consortium board of directors has approved new national laboratory standards for testing, the implementation of a laboratory accreditation program and a new independent Equine Quality Assurance Program.
Time and money are two of the major roadblocks as the horse racing industry struggles to come to terms with medication, drug testing, and security, officials said March 4 during the joint annual meeting of Harness Tracks of America and the Thoroughbred Racing Associations.
Testing of post race samples for erythropoietin and darbepoietin antibodies will begin Nov. 1 in New York under an emergency rule approved Oct. 21 by the state's Racing and Wagering Board.
Most Popular Stories
- Top Stallion Street Cry Dead at Age 16
- HRRN Programming on New SiriusXM Channels
- Is PA Derby Best Spot for 'Chrome'?
- Keeneland September Sale Sees More Gains
- No Dice for Massachusetts Racing, Breeding
- California Chrome Draws Rail in PA Derby
- California Chrome Arrives at Parx Racing
- What's Going On Here: Solid at the Core
- Injury Forces Sea The Moon's Retirement
- Suffolk Downs Loses Casino Bid on 3-1 Vote